CoChat
Sign Up
Cited by 295Autism Spectrum Disorder ResearchChild Nutrition and Feeding IssuesBehavioral and Psychological Studies

The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.

Pharmacologic Treatment of Severe Irritability and Problem Behaviors in Autism: A Systematic Review and Meta-analysis

Fung, Lawrence K., Mahajan, Rajneesh, Nozzolillo, Alixandra, Bernal, Pilar, Krasner, Aaron, Jo, Booil, Coury, Daniel, Whitaker, Agnes, Veenstra-Vanderweele, Jeremy, Hardan, Antonio Y.·2016·Pediatrics
DOI 10.1542/peds.2015-2851k
Open this paper in CoChat — free account

Abstract

BACKGROUND: Autism spectrum disorder (ASD) is increasingly recognized as a public health issue. Irritability and aggression (IA) often negatively affect the lives of people with ASD and their families. Although many medications have been tested for IA in ASDs in randomized controlled trials (RCTs), critical quantitative analyses of these trials are lacking in the literature. OBJECTIVES: To systematically review and quantitatively analyze the efficacy and safety of pharmacologic treatments for IA in youth with ASD. DATA SOURCES: Studies were identified from Medline, PsycINFO, Embase, and review articles. METHODS: Original articles on placebo-controlled RCTs of pharmacologic treatments of IA in youth age 2 to 17 years with ASD were included. Data items included study design, study goals, details of study participants, details of intervention, study results, statistical methods, side effects, and risks of bias. The primary study outcome measure was the effect size of reduction in the Aberrant Behavioral Checklist–Irritability (ABC-I) scores in the medication group, as compared with placebo, in RCTs using parallel groups design. RESULTS: Forty-six RCTs were identified. Compared with placebo, 3 compounds resulted in significant improvement in ABC-I at the end of treatment. Risperidone and aripiprazole were found to be the most effective, with the largest effect sizes. Sedation, extrapyramidal sides effects, and weight gain were assessed quantitatively. CONCLUSIONS: Although risperidone and aripiprazole have the strongest evidence in reducing ABC-I in youth with ASD, a few other compounds also showed significant efficacy with fewer potential side effects and adverse reactions in single studies.

Overview

Integrity signals

Registry

Crossref · 10.1542/peds.2015-2851k

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 63 references

Research works printed but not linked: 1

  1. Vorvick, 2009, Irritability

Cited by

Sorted by citations

Items 201–295 of 295

Related

See all

Metadata

Authors
Fung, L. K., Mahajan, R., Nozzolillo, A., Bernal, P., Krasner, A., Jo, B., Coury, D., Whitaker, A., Veenstra-Vanderweele, J., & Hardan, A. Y.
Affiliations
  • Stanford University (US)
  • Kennedy Krieger Institute (US)
  • Massachusetts General Hospital (US)
  • Kaiser Permanente Northern California (US)
  • NewYork–Presbyterian Hospital (US)
  • The Ohio State University (US)
ORCID
Venue
Pediatrics
Publisher
American Academy of Pediatrics (AAP)
Published
2016-02-01
Volume
137
Issue
Supplement_2
Pages
S124-S135
ISSN
  • 0031-4005 (ISSN-L)
  • 1098-4275
DOI
10.1542/peds.2015-2851k
OpenAlex
W2280843891
Cited by
294
References
63
Citations by year
2026: 18 · 2025: 25 · 2024: 27 · 2023: 34 · 2022: 34 · 2021: 49 · 2020: 44 · 2019: 24 · 2018: 21 · 2017: 11 · 2016: 7
FWCI
2.21
Type
journal article
Language
en
Open access
closed
Locations
  • PEDIATRICS (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Health Sciences › Medicine › Psychiatry and Mental health › Child Nutrition and Feeding Issues
  • Social Sciences › Psychology › Developmental and Educational Psychology › Behavioral and Psychological Studies
Keywords
autism spectrum disorder, irritability, aggression, behavioral problems, pharmacotherapy, risperidone, aripiprazole, adverse drug reactions, sedation, extrapyramidal symptoms, weight gain, youth
MeSH terms
Problem Behavior, Autism Spectrum Disorder, Aripiprazole, Adolescent, Child, Child Development Disorders, Pervasive, Child, Preschool, Humans, Irritable Mood, Antipsychotic Agents, Self-Injurious Behavior, Risperidone

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review